The BalancedInvestor Club

Drug Manufacturers Specialty Generic Industry Analysis

89 companies analyzed • Returns from -331.7% to +338.7%

Company List (89 Results)

View:
Sort:

Industry Performance

(89/89 companies)
2025-09-02 → 2026-08-31
Weighted Avg
-4.7%
Best
+338.7%
Worst
-331.7%
Returns Distribution
Top 5
1. ASRT+338.7%2. SCYX+183.4%3. IXHL+165.8%4. RMTI+151.3%5. TLRY+129.6%
Bottom 5
1. BGM-331.7%2. ZYBT-199.1%3. BFRIW-169.2%4. SBFMW-161.3%5. FLGC-143.5%

ASRT

+338.7%

Assertio Therapeutics Inc

SCYX

+183.4%

Scynexis Inc

IXHL

+165.8%

Incannex Healthcare Ltd ADR

RMTI

+151.3%

Rockwell Medical Inc

TLRY

+129.6%

Tilray Inc

INCR

+126.2%

INC Research Holdings Inc

ETON

+125.7%

Eton Pharmaceuticals Inc

IRWD

+117.7%

Ironwood Pharmaceuticals Inc

KNSA

+83.0%

Kiniksa Pharmaceuticals Ltd

ANIK

+82.5%

Anika Therapeutics Inc

TLPH

+79.0%

Talphera Inc.

EVOK

+74.9%

Evoke Pharma Inc

APUS

+73.1%

Apimeds Pharmaceuticals US, Inc.

TXMD

+72.1%

TherapeuticsMD Inc

BIOA

+71.4%

BioAge Labs, Inc

TEVA

+65.4%

Teva Pharma Industries Ltd ADR

LNTH

+60.2%

Lantheus Holdings Inc

AMRX

+60.1%

Amneal Pharmaceuticals, Inc. Class A Common Stock

BFRI

+60.0%

Biofrontera Inc

CPIX

+59.5%

Cumberland Pharmaceuticals Inc

1–20 of 89
Page 1 of 5
Methodology

The Weighted Average return (-4.7%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

85 companies with market cap data included: ASRT, SCYX, IXHL, RMTI, TLRY, INCR, ETON, IRWD, KNSA, ANIK and 75 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer